Virtus LifeSci Biotech Clinical Trials ETF

Virtus LifeSci Biotech Clinical Trials ETF is an ETF issued by Virtus Investment Partners, Inc. on Dec 16 2014. The main focus of this ETF, which is in the "Equity" asset class, is determined as "Health care". As of today, the price of BBC ETF according to its net asset value is discounted at -0.28%. While the total value of the fund shows $6.36M increase compared to the previous month, its price is traded daily at a increase of 2.60%. The annual dividend yield of BBC ETF is 0.64%, whereas its main asset area is North America. BBC ETF, whose 24-hour total volume is $47K, has experienced a $3.75M cash inflow in the last month. In addition, Virtus LifeSci Biotech Clinical Trials ETF's one-year net asset value total return is 37.59%.